欢迎进入 投资云南@云南招商网

州市招商

文山

项目查询

关键字:
所属行业:
投资金额:
- 万元
 
您现在的位置是: 首页--生物医药和大健康--详细
辅酶Q10终端产品产业化项目Coenzyme Q10 End Product Industrialization Project
发布时间:2016-07-07 14:41:56   来源:本站   作者:   点击:496次

Name

辅酶Q10终端产品产业化项目

Coenzyme Q10 End Product Industrialization Project

Industry Involved

Modern Bio-medicine

Site

IIT Plot, Southern Block, Yuxi National Hi-tech Zone

Description

Yuxi Jiankun BioPharma Co. Ltd. has been committed to comprehensive development and utilization of tobacco waste for many years and has the production capacity of coenzyme Q10 at present. Coenzyme Q10 can activate human cells and cellular energy nutrition and has such functions as improving immune capability, enhancing antioxidant capacity, delaying senescence and enhancing vitality of human. In recent years, it has been extensively used both home and abroad as dietary supplements and food additives. To extend industrial chain and increase the added value of the product, the company hopes to introduce partners and realize industrialization of coenzyme Q10 end products.

Content

Construction scale: Total floor area of this project is 33,670 m2. It includes the construction of fermentation workshop, extraction workshop, refined extraction workshop, soft capsule production workshop, toothpaste production workshop, coenzyme Q10 electuary production workshop, raw material warehouse, finished goods warehouse, comprehensive office building, living service area and public utilities. After completion, the production scale will be 20 million bottles of coenzyme Q10 soft capsules, 10 million tubes of coenzyme Q10 toothpastes, 5t reduced coenzyme Q10, 6 million bottles of water-soluble coenzyme Q10 electuaries each year.

Construction duration: 2 years

Land area: 37.1 mu

Supporting Conditions

Yuxi New & High-tech Industrial Development Zone is located in central city area of Yuxi City and is a national level new & high-tech industrial development zone approved by the State Council. It is 88 km from Kunming and about an hour's drive from Changshui International Airport. After Kunming-Yuxi inter-city trains are put into service, it is possible to reach Kunming within half an hour. It is the national level new & high-tech industrial development zone that is the closest to South Asian and Southeast Asian countries and areas. In 2014, this zone realized a total output value of RMB 43.16 billion, with a year-on-year growth of 8.2% and accounting for 36.4% the total output value of the whole city. This zone has introduced 15 bio-pharmaceutical enterprises including Walvax Biotechnology Co., Ltd., Weihe Pharma and Jiankun BioPharma and basically built a bio-medical cluster with new drugs as lead, generic drugs as base, original drug as backup force and vaccine as characteristic. Main raw material of coenzyme Q10 products is tobacco waste. Yuxi is one of the largest flue-cured tobacco and cigarette production regions in China and has rich main raw material for this project. Currently, Yuxi Jiankun BioPharma Co. Ltd. is one of the largest manufacturing enterprises for coenzyme Q10 active pharmaceutical ingredients in China. Coenzyme Q10 active pharmaceutical ingredients manufactured by it are granted the approval number, GMP certificate and production license issued by China Food and Drug Administration. At present, feasibility study on expansion of this project is under way.

Investment Estimate and Fund Raising

Investment estimate: A total investment of RMB 194,476,000, including RMB 74,476,000 of self-raised funds and RMB 120 million from financial institutions.

Fund raising: self raising by enterprise and bank loans

Preferential Policies Applicable

It can enjoy the preferential policies on investment promotion for Yuxi National Level High-tech Zone.

Market Prediction (Analysis)

Coenzyme Q10 is the only market-available natural dietary supplement which can both retard and eliminate the decrease of cell activity and the insufficient anti-free radical oxidation. Coenzyme Q10 has efficacy in immunity enhancement, beautification, anti-aging, heart health, weight loss and the like. So far, China has formed a coenzyme Q10 products market structure with medicines and health care products as main product and a brand market structure with domestic brands as main brand. In 2013, the output of domestic coenzyme Q10 was about 400t and 90% of it was exported. In the largest U.S. market worldwide, Q10 raw material of China also represents the largest piece in terms of quantity. It is reported that coenzyme Q10 is mainly consumed by U.S., Japan, Western Europe and Australia. Among them, U.S. market took up one third the total consumption. In 2013, twenty-nine varieties of active pharmaceutical ingredients in total exceeded USD 100 million in export sales and coenzyme Q10 ranked 24 with an export sales of USD 116.21 million, with a year-on-year growth of 13.83%. With the improvement of living standard, the demand of health care product and cosmetic markets on coenzyme Q10 will be larger and larger.

Profit Model and Preliminary Benefit Analysis

Economic benefit: After this project reaches the design capacity, annual sales revenue of coenzyme Q10 products may reach RMB 527.50 million; corporate income tax may reach RMB 25.639 million; annual net profit may reach RMB 76.917 million; the payback period is 4.5 years (including 2 years of construction period).

Social benefit: This project will promote the development of coenzyme Q10 industry in Yuxi City, extend industrial chain, and increase job opportunity.

Risk Analysis

As a kind of dietary supplement, coenzyme Q10 has no high profile in China and consumer recognition needs to be elevated. Therefore, main risks are market recognition risk and intense competition from domestic market due to introduction of foreign products.

Cooperation Pattern

Financing, share buying, holding or wholly-owned acquisition

Contact Information

Contact Unit: Yuxi Jiankun BioPharma Co. Ltd.

Contact Person: Chen Linxian

Tel.: 13908895200

E-mail: yxgxq@126.com

关于我们| 商会平台| 信息公开| 联系我们 滇ICP备08002862号

0871-67195654/67195610

电子邮件:yunnanzs@163.com

云南招商官方微信

法制在线官方微信

管理员登录      不良信息报警      云南网监      网站备案      平台入口      招商大数据平台项目查询系统